Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS) NSE

201.40

-0.6(-0.30%)

Updated at December 24 03:29PM

Currency In INR

Valuation

Market Cap14.62B
Enterprise Value13.42B
P/E Ratio21.61
PEG Ratio12.21
Price/Sales Ratio4.73
Price/Book Ratio5.29
Enterprise/Revenue4.71
Enterprise/EBITDA15.44

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.22
Operating Margin0.16

Management Effectiveness

Return On Assets0.21
Return On Equity0.27

Income Statement

Revenue2.69B
Revenue/Share42.26
Gross Profit1.72B
EBITDA510.71M
Net Income553.61M
Diluted EPS8.22

Balance Sheet

Total Cash1.59B
Total Cash/Share23.82
Total Debt88.36M
Total Debt/Equity0.03
Current Ratio6.07
Book Value Per Share37.8

Price History

52-Week Change-21.43
52-Week High301.65
52-Week Low192.85
Moving Average 50 Days210.56
Moving Average 200 Days227.19

Statistics

Average Volume67,253
Shares Outstanding66.78M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate2.5
Trailing Annual Dividend Yield1.25
Payout Ratio0
Last Split Factor8:1
Last Split DateJuly 20, 2004